Brain Tumors Research Today is a free monthly online journal that collates and summarizes the latest research about Brain Tumors, including details on symptoms, benign and malignant tumors, gliomas, screening, treatment.

Volume 5 (2008), Issue 3 (March)

1. Routine measurement of head circumference as a tool for detecting intracranial expansion in infants: what is the gain? A nationwide survey.
   Pediatrics, 121(3): e416-20. [Abstract] [Full-text]
2. Multi-institutional phase II study of temozolomide administered twice daily in the treatment of recurrent high-grade gliomas.
   Cancer, 112(5): 1139-46. [Abstract] [Full-text]
3. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence.
   J Neurosurg, 108(3): 525-32. [Abstract] [Full-text]
4. Intermittent atlantoaxial subluxation caused by a prolapsing neurofibroma. Case report.
   J Neurosurg Spine, 8(3): 288-91. [Abstract] [Full-text]
5. A multicenter cohort study of dose-dense temozolomide (21 of 28 days) for the treatment of recurrent anaplastic astrocytoma or oligoastrocytoma.
   Cancer Invest, 26(3): 269-77. [Abstract] [Full-text]
6. Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence.
   Neurology, 70(10): 779-87. [Abstract] [Full-text]
7. Erlotinib in patients with previously irradiated, recurrent brain metastases from non-small cell lung cancer: two case reports.
   Onkologie, 31(3): 123-6. [Abstract] [Full-text]
8. Complete response of CNS-involved olfactory neuroendocrine tumor using multimodal therapy.
   Onkologie, 31(3): 119-21. [Abstract] [Full-text]
9. Isolated bone marrow natural killer cell lymphoma with central nervous system involvement mimicking a cerebral infarct.
   Onkologie, 31(3): 115-7. [Abstract] [Full-text]
10. Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas.
    J Clin Oncol, 26(8): 1338-45. [Abstract] [Full-text]
11. Yes and PI3K bind CD95 to signal invasion of glioblastoma.
    Cancer Cell, 13(3): 235-48. [Abstract] [Full-text]
12. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion.
    Cancer Cell, 13(3): 206-20. [Abstract] [Full-text]
13. Correlation between 6q25.3 deletion status and survival in pediatric intracranial ependymomas.
    Cancer Genet Cytogenet, 182(1): 18-26. [Abstract] [Full-text]
14. Extent of extracranial disease is a powerful predictor of survival in patients with brain metastases from gynecological cancer.
    Int J Gynecol Cancer, 18(2): 262-8. [Abstract] [Full-text]
15. Chordoid glioma: report of two rare examples with unusual features.
    Acta Neurochir (Wien), 150(3): 295-300; discussion 300. [Abstract] [Full-text]
16. Inhibition of N-(4-hydroxyphenyl)retinamide-induced autophagy at a lower dose enhances cell death in malignant glioma cells.
    Carcinogenesis, 29(3): 600-9. [Abstract] [Full-text]
17. The protein phosphatase activity of PTEN regulates SRC family kinases and controls glioma migration.
    Cancer Res, 68(6): 1862-71. [Abstract] [Full-text]
18. The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.
    Cancer Res, 68(6): 1768-76. [Abstract] [Full-text]
19. Primary intracerebral angiomatoid fibrous histiocytoma: report of a case with a t(12;22)(q13;q12) causing type 1 fusion of the EWS and ATF-1 genes.
    Am J Surg Pathol, 32(3): 478-84. [Abstract] [Full-text]
20. Transtemporal-transchoroidal approach and its transamygdala extension to the posterior chiasmatic cistern and diencephalo-mesencephalic lesions.
    Acta Neurochir (Wien), 150(4): 317-27; discussion 327-8. [Abstract] [Full-text]
21. Peri-operative glucocorticoid replacement therapy in transsphenoidal pituitary adenoma surgery: a prospective controlled study.
    Acta Neurochir (Wien), 150(4): 329-35; discussion 335. [Abstract] [Full-text]
22. The relationship between intracranial pressure and the degree of brain swelling in patients subjected to infratentorial surgery.
    Acta Neurochir (Wien), 150(4): 337-44; discussion 344. [Abstract] [Full-text]
23. What is the value of emission tomography studies in patients with a primary glioblastoma multiforme treated by 192Ir brachytherapy?
    Acta Neurochir (Wien), 150(4): 345-9. [Abstract] [Full-text]
24. Bradykinin increases blood-tumor barrier permeability by down-regulating the expression levels of ZO-1, occludin, and claudin-5 and rearranging actin cytoskeleton.
    J Neurosci Res, 86(5): 1153-68. [Abstract] [Full-text]
25. Therapeutic targets for medulloblastoma.
    Expert Opin Ther Targets, 12(4): 449-61. [Abstract] [Full-text]
26. Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma.
    Nat Clin Pract Endocrinol Metab, 4(4): 234-8. [Abstract] [Full-text]
27. 1p36 is a preferential target of chromosome 1 deletions in astrocytic tumours and homozygously deleted in a subset of glioblastomas.
    Oncogene, 27(14): 2097-108. [Abstract] [Full-text]
28. The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids.
    Oncogene, 27(14): 2091-6. [Abstract] [Full-text]
29. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
    Radiology, 247(1): 170-8. [Abstract] [Full-text]

© 2004-2008 Brain Tumors Research Today. All Rights Reserved.